Improving cancer outcomes with better Lynch syndrome testing: A cost-benefit study

While testing of colorectal cancer tumors for mismatch repair (MMR) defects has been recommended for years, the majority of patients with abnormal results do not complete the next steps, including genetic testing. Skipping those steps can cause missed cancer diagnoses and unnecessary costs, as explained in a Yale study recently published in the journal Clinical Gastroenterology and Hepatology.

👉 Full Story